Literature DB >> 10623971

Violent patients in the emergency setting.

L Citrome1, J Volavka.   

Abstract

Violent or threatening behavior is a common reason for presentation to the ED. Patients with aggressive behavior must first be assessed for the possibility of comorbid medical conditions. Acute withdrawal from alcohol or sedatives needs to be ruled out. Short-term sedation with lorazepam is a safe and effective choice for managing patients with acute agitation. The use of typical neuroleptics may lead to side effects, such as akathisia, which may in turn precipitate additional agitation. This may be obviated with the introduction of IM preparations of atypical antipsychotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10623971     DOI: 10.1016/s0193-953x(05)70126-x

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  8 in total

1.  Aggression and increased glutamate in the mPFC during withdrawal from intermittent alcohol in outbred mice.

Authors:  Lara S Hwa; Anna J Nathanson; Akiko Shimamoto; Jillian K Tayeh; Allison R Wilens; Elizabeth N Holly; Emily L Newman; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-04-22       Impact factor: 4.530

Review 2.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Pharmacological management of acute agitation.

Authors:  John Battaglia
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Alcohol and violence: neuropeptidergic modulation of monoamine systems.

Authors:  Klaus A Miczek; Joseph F DeBold; Lara S Hwa; Emily L Newman; Rosa M M de Almeida
Journal:  Ann N Y Acad Sci       Date:  2015-08-18       Impact factor: 5.691

5.  The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.

Authors:  Michael P Wilson; David Pepper; Glenn W Currier; Garland H Holloman; David Feifel
Journal:  West J Emerg Med       Date:  2012-02

6.  Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents.

Authors:  Leslie Citrome
Journal:  Ther Clin Risk Manag       Date:  2013-05-20       Impact factor: 2.423

7.  Unrecognized hypoxia and respiratory depression in emergency department patients sedated for psychomotor agitation: pilot study.

Authors:  Kenneth Deitch; Adam Rowden; Kathia Damiron; Claudia Lares; Nino Oqroshidze; Elizabeth Aguilera
Journal:  West J Emerg Med       Date:  2014-07

Review 8.  Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Authors:  Justin Faden; Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-07       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.